Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDunedin Ent.it. Regulatory News (DNE)

  • This share is currently suspended. It was suspended at a price of 470.00

Share Price Information for Dunedin Ent.it. (DNE)

Share Price is delayed by 15 minutes
Get Live Data
470.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: -
DNE Live PriceLast checked at - London Stock Exchange

Intraday Dunedin Ent.it. Share Chart

Portfolio Update

13 Oct 2021 10:00

RNS Number : 9270O
Dunedin Enterprise Inv Trust PLC
13 October 2021
 

Dunedin Enterprise Investment Trust PLC

 

LEI: 213800E2VLUZ5AF9Z434

 

Date: 13 October 2021

 

 

Partial realisation of Global Processing Services ("GPS")

 

Dunedin Enterprise Investment Trust PLC is pleased to announce that Dunedin Buyout Fund III LP has entered into a legally binding agreement for the partial realisation of its investment in GPS, a market leader in payment processing technology.

 

The investment in GPS was valued at £16.1m at 30 June 2021. Proceeds from the partial sale will amount to £18.2m, consisting of capital of £16.0m and income of £2.2m. In addition, £5.9m will be rolled into a GPS newco resulting in a total consideration of £24.1m. This represents an uplift of £8m on the 30 June 2021 valuation, equivalent to 44.1p per share.

 

The transaction is subject to regulatory approval and is expected to complete by the end of 2021. The effect of the transaction will be reflected in the net asset value as at 30 September 2021, which is due to be published on or around 1 November 2021.

 

 

 

END

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PFUFIFSRIILVLIL
Date   Source Headline
29th Jan 20251:17 pmRNSStatement re First Distribution in Liquidation
6th Jan 20252:48 pmRNSResult of General Meeting
30th Dec 20245:30 pmRNSDunedin Enterprise Investment Trust
19th Dec 20243:38 pmRNSGM - Announcement of Suspension Timetable
19th Dec 20243:27 pmRNSGM - Announcement of Suspension Timetable
9th Dec 20247:00 amRNSHolding(s) in Company
4th Dec 202410:00 amRNSGeneral Meeting re: Member's Voluntary Liquidation
4th Dec 202410:00 amRNSPublication of Circular and Winding-up Timetable
3rd Dec 20248:44 amRNSGeneral Meeting re: Member's Voluntary Liquidation
29th Nov 20241:38 pmRNSPortfolio Update
1st Nov 20247:00 amRNSPreliminary Unaudited Net Asset Value at 30/09/24
11th Sep 20247:00 amRNSHalf-year Report
27th Aug 20247:00 amRNSDividend Declaration
5th Aug 20247:00 amRNSPortfolio Update
1st Aug 20247:00 amRNSPreliminary unaudited net asset value at 30/6/24
15th May 20241:17 pmRNS1st Quarter Results
15th May 20241:12 pmRNSResult of AGM
7th May 20245:37 pmRNSHolding(s) in Company
1st May 20247:00 amRNSPreliminary Unaudited Net Asset Value at 31/3/24
22nd Mar 20247:00 amRNSAnnual Financial Report
5th Feb 20241:58 pmRNSHolding(s) in Company
5th Feb 20241:56 pmRNSHolding(s) in Company
5th Feb 20241:54 pmRNSHolding(s) in Company
1st Feb 20247:00 amRNSPreliminary Unaudited Net Asset Value at 31/12/23
19th Dec 20232:34 pmRNSHolding(s) in Company
19th Dec 20232:22 pmRNSHolding(s) in Company
13th Dec 20237:00 amRNSDividend Declaration
21st Nov 20237:00 amRNSPremier Hytemp realisation & potential winding-up
16th Nov 20237:00 amRNS3rd Quarter Results
6th Nov 20234:33 pmRNSHolding(s) in Company
3rd Nov 20237:05 amRNSPortfolio Update
1st Nov 20237:00 amRNSPreliminary Unaudited Net Asset Value at 30/9/23
28th Sep 20237:00 amRNSPortfolio Update
15th Sep 20237:00 amRNSHalf-year Report
1st Aug 20237:00 amRNSPreliminary unaudited net asset value at 30/6/23
6th Jun 20239:01 amRNSHolding(s) in Company
22nd May 202310:05 amRNSHolding(s) in Company
10th May 20232:42 pmRNSResult of AGM
10th May 20232:42 pmRNS1st Quarter Results
2nd May 20237:00 amRNSPreliminary unaudited net asset value at 31/3/23
24th Mar 20237:00 amRNSAnnual Financial Report
1st Feb 20237:00 amRNSPreliminary Unaudited Net Asset Value at 31/12/22
7th Dec 20221:02 pmRNSDirector/PDMR Shareholding
7th Dec 20221:00 pmRNSDirector/PDMR Shareholding
7th Dec 20221:00 pmRNSDirector/PDMR Shareholding
6th Dec 202211:12 amRNSDirector/PDMR Shareholding
6th Dec 202211:09 amRNSDirector/PDMR Shareholding
1st Dec 202212:42 pmRNSHolding(s) in Company
30th Nov 20225:50 pmRNSDirector/PDMR Shareholding
30th Nov 20225:48 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.